Navigation Links
VIASPACE Granted US Patent
Date:3/10/2009

PASADENA, Calif., March 10 /PRNewswire-FirstCall/ -- VIASPACE Inc. (OTC Bulletin Board: VSPC) announced today that the United States Patent and Trademark Office issued patent number 7, 499,169 to VIASPACE on March 3, 2009. The patent covers detection and measurement of water vapor (humidity) in gas streams for fuel cells and exhaust streams from combustion processes such as automobiles and factory smokestacks. Inventors are Nathan Hurvitz and VIASPACE CEO Dr. Carl Kukkonen.

VIASPACE's HS-1000 humidity sensor product is now protected by this patent. The HS-1000 uses a laser to make real-time measurements of water vapor in air or other gas streams. Humidity measurements are crucial for testing and optimization of hydrogen fuel cells and the HS-1000 has been sold to leading fuel cell developers and researchers worldwide. The other major application covered by the patent is to measure humidity in the products of combustion. Gasoline or natural gas, when burned in air, produce water vapor as a combustion product. Precise measurement of the water vapor in the exhaust may be a crucial indicator of the efficiency of combustion and the effective "miles per gallon" achieved.

One international customer extensively compared the VIASPACE HS-1000 to two leading competitors and the HS-1000 won the competition. HS-1000 customers include Ballard Power Systems, 3M, US National Renewable Energy Laboratory, Tokyo Institute of Technology and a leading worldwide automobile manufacturer.

About VIASPACE (OTCBB: VSPC) -- VIASPACE was founded in 1998 and became a public company in 2005. VIASPACE focuses on clean and alternative energy including disposable fuel cell cartridges, and a proprietary fast-growing grass as a feedstock for biofuels and for animal feed. For more information, please see www.VIASPACE.com or contact Dr. Jan Vandersande, Director of Communications, at 800-517-8050 or IR@VIASPACE.com.

This news release includes forward-looking statements. These forward-looking statements relate to future events or our future performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Such factors include without limitation the risks outlined in our periodic filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-KSB, for the fiscal year ended December 31, 2007, as well as general economic and business conditions, the ability to acquire and develop specific projects and technologies, the ability to fund operations, changes in consumer and business consumption habits, competition with larger companies, demand for biofuels and animal feed particularly in China, risks associated with international transactions, crop development, growing, and harvesting related risks, and other factors over which VIASPACE has little or no control.


'/>"/>
SOURCE VIASPACE Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. VIASPACE Plants Biofuel & Animal Feed Grass and Signs Land Lease in China
2. Crisis Exemption Granted to Market Avipel(R) Corn Seed Treatment in Louisiana
3. Valdoxan(R) Granted Marketing Authorisation for the Treatment of Major Depressive Episodes in Europe
4. Odyssey Thera Granted U.S. Patent for Novel GPCR Assay Strategy
5. GeneNews granted U.S. patent for Chagas disease based on Sentinel Principle(TM) platform
6. BioLife Solutions Granted European Biopreservation Patent
7. ScinoPharm Granted US Patent for Novel Crystal Forms
8. Memory Pharmaceuticals Granted Extension to Comply with NASDAQ Listing Requirements
9. MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process
10. Autonomy(TM) Lapro-Angle(TM) Articulating Laparoscopic Instruments Granted CE Mark
11. Wyeths Motion to Overturn Punitive Damages Award Granted by Arkansas Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... DuPont Pioneer and recently formed CasZyme, ... into a multiyear collaboration to identify and characterize novel CRISPR-Cas nucleases. The goal ... editing across all applications. , Under the terms of the agreement, Pioneer will ...
(Date:10/11/2017)... ... October 11, 2017 , ... At ... Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist ... has been selected for membership in ARCS Alumni Hall of Fame . ...
(Date:10/11/2017)...  VMS BioMarketing, a leading provider of patient support solutions, ... Educator (CNE) network, which will launch this week. The VMS ... care professionals to enhance the patient care experience by delivering ... health care professionals to help women who have been diagnosed ... ...
(Date:10/10/2017)... ... ... San Diego-based team building and cooking events company, Lajollacooks4u, has unveiled a ... new look is part of a transformation to increase awareness, appeal to new markets ... It will also expand its service offering from its signature gourmet cooking classes and ...
Breaking Biology Technology:
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/4/2017)...   EyeLock LLC , a leader of iris-based ... Patent and Trademark Office (USPTO) has issued U.S. Patent ... an iris image with a face image acquired in ... 45 th issued patent. "The ... the multi-modal biometric capabilities that have recently come to ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
Breaking Biology News(10 mins):